Researchers discover new type of memory B cell that remembers allergies
The cell could be a target for new immunotherapies for the chronic disease
Read More
Tag: ALK-Abello
EU expands approval of ALK’s house dust mite pill
European regulators have expanded the scope of ALK-Abello’s Acarizax to include the treatment of adolescent patients with house dust mite-induced allergic rhinitis.
Read More
- Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
- Royal Marsden launches first UK genome testing facility to improve testing for cancer
- Sysmex receives Longitude Prize on AMR for antimicrobial testing system
- LifeArc funds new projects to address and prevent global threat of dengue fever
- New study reveals how brain cell communication is linked to Alzheimer’s disease
